Team:ULB-Brussels/sponsors

From 2011.igem.org

(Difference between revisions)
(Created page with "<html> <head> <style> #menubar .left-menu noprint{ color: white; } .right-menu{ background: none; } #content { background: none; padding:0; width:100%; border:0; mar...")
 
(19 intermediate revisions not shown)
Line 2: Line 2:
<head>
<head>
     <style>
     <style>
 +
 +
table
 +
{
 +
margin: auto;
 +
width: 700px;
 +
padding: 20px;
 +
}
 +
 +
td
 +
{
 +
padding-top: 10px;
 +
padding-bottom: 10px;
 +
}
#menubar .left-menu noprint{
#menubar .left-menu noprint{
Line 105: Line 118:
{
{
width:980px;
width:980px;
-
height:430px;
+
height:860px;
margin: auto;
margin: auto;
padding-left: 5px;
padding-left: 5px;
Line 138: Line 151:
padding: 4px;
padding: 4px;
width:980px;
width:980px;
-
height: 392px;
+
min-height: 392px;
border: 2px inset #27303e;  
border: 2px inset #27303e;  
text-align: justify;
text-align: justify;
Line 539: Line 552:
<a href="https://2011.igem.org/Team:ULB-Brussels">Home</a>
<a href="https://2011.igem.org/Team:ULB-Brussels">Home</a>
<a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a>
<a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a>
-
<a href="https://2011.igem.org/Team:ULB-Brussels/modeling">Modeling</a>
+
<a     href="https://2011.igem.org/Team:ULB-Brussels/modeling">Modelling</a>
-
<a href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a>
+
<a href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a>
-
<a href="https://2011.igem.org/Team:ULB-Brussels/Results">Results</a>
+
<a href="https://2011.igem.org/Team:ULB-Brussels/Discussion">Discussion</a>
-
<a href="https://2011.igem.org/Team:ULB-Brussels/parts">Parts</a>
+
<a href="https://2011.igem.org/Team:ULB-Brussels/parts">Parts</a>
<a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a>
<a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a>
<a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a>
<a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a>
-
<a id="couleur" href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a>
+
<a id="couleur" href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a>
 +
 
</div>
</div>
Line 553: Line 567:
<div id="maintext">
<div id="maintext">
<div id="hmaint">
<div id="hmaint">
-
Thanks for the support our sponsors have given us. </div>
+
Sponsors </div>
<div id="maint">
<div id="maint">
-
<P>1. Would any of your project ideas raise safety issues in terms of: researcher safety, public safety, or environmental safety?</p>
 
-
<strong>Our project doesn’t involve producing dangerous products, or any modification that could be pathogen. There is no evident issues concerning public or the researcher’s safety , except the well-known risks of all molecular biology researches. Of course, any bacterial modification implies the risk of genetic transduction in other bacteria, which consequences we cannot predict</strong>
+
  <table>
-
<P>2.Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? </p>
+
<tr>
-
<strong>No, all of the BioBricks we are going to send will be made from DNA parts usually used in our host lab, with no particular safety issues.</strong>
+
<td><a href="http://www.ucb.com/"><img src="https://static.igem.org/mediawiki/2011/a/a4/Logo-ucb.png" alt="UCB's logo" /></a>
-
<p>3.Is there a local biosafety group, committee, or review board at your institution?</p>
+
<td><em>UCB</em>, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2010. UCB is listed on Euronext Brussels.</td>
-
<strong>Yes, there is a biosafety committee specific of the ULB Institute of Molecular Biology and Medicine, which was our host lab. This committee authorizes or refuses any new project to be carried in the institute, including end of studies works and thesis, which is routine, except if the project includes, for example, the manipulation of pathogenic organisms.</strong>
+
</tr>
-
<p>3.1. If yes, what does your local biosafety group think about your project?</p>
+
<tr>
-
<strong>Since all the DNA parts we designed were already used, in different projects in our host lab, our project was considered routine and was not subject to any specific decision of the committee. We didn’t have special presentations to do or forms to fill and obtained quite automatically the authorization to manipulate.</strong>
+
<td><a href="http://www.delphigenetics.com/"><img src="https://static.igem.org/mediawiki/2011/c/c4/Logo-delphi.png" alt="Delphi's logo" /></a>
-
<p>4.Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</p>
+
<td><em>Delphi Genetics</em> was founded by Philipe Gabant in 2001 and their HQ is located in Gosselies in Belgium. Their main interest lies in research on more effective products and techniques for gene cloning and protein expression in bacteria, based on poison-antidote systems.</td>
-
<strong>Perhaps potential pathogens or environmentally problematic parts should be referenced, with a dangerousness rate, based on a standard classification.</strong>
+
</tr>
 +
<tr>
 +
<td><a href="http://www.ulb.ac.be/facs/sciences/index.html"><img src="https://static.igem.org/mediawiki/2011/0/0e/Logo-fac-sciences.PNG" alt="Faculté des Sciences' logo" /></a>
 +
<td>Our team is mostly composed of students from this faculty. They have been supporting us for now 3 years.</td>
 +
</tr>
 +
<tr>
 +
<td><a href="http://www.ulb.ac.be/"><img src="https://static.igem.org/mediawiki/2011/9/96/Logo-ulb.png" alt="ULB's logo" /></a>
 +
<td>The <em>Université Libre de Bruxelles</em>, our university.</td>
 +
</tr>
 +
<tr>
 +
<td><a href="http://www.ulb.ac.be/brachet/actions.html"><img src="https://static.igem.org/mediawiki/2011/3/36/Logo-fond-brachet.png" alt="Fond Brachet's logo" /></a>
 +
<td>The <em>Fonds Jean Brachet</em> was founded in 1985 by professors, researchers and former students from the Molecular Biology Department of the ULB. Its main aim ? Collecting funds to help researchers in all possible ways.</td>
 +
</tr>
 +
 
 +
 
 +
 
 +
  </table>
 +
 
 +
 
</div>
</div>
</div>
</div>

Latest revision as of 17:43, 21 September 2011

Sponsors
UCB's logo UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2010. UCB is listed on Euronext Brussels.
Delphi's logo Delphi Genetics was founded by Philipe Gabant in 2001 and their HQ is located in Gosselies in Belgium. Their main interest lies in research on more effective products and techniques for gene cloning and protein expression in bacteria, based on poison-antidote systems.
Faculté des Sciences' logo Our team is mostly composed of students from this faculty. They have been supporting us for now 3 years.
ULB's logo The Université Libre de Bruxelles, our university.
Fond Brachet's logo The Fonds Jean Brachet was founded in 1985 by professors, researchers and former students from the Molecular Biology Department of the ULB. Its main aim ? Collecting funds to help researchers in all possible ways.
iGEM ULB Brussels Team - Contact us